Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting Mathieu MolimardIoannis KottakisIvan Nikolaev Review Article Open access 25 March 2021 Pages: 415 - 424
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder Joao P. De AquinoSuprit ParidaMehmet Sofuoglu Review Article 05 April 2021 Pages: 425 - 436
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections Mariacristina PolisenoDavide Fiore BavaroSergio Carbonara Original Research Article Open access 21 April 2021 Pages: 437 - 448
Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Jocelyn Y. ChengMargaret MolineNancy Hall Original Research Article 16 March 2021 Pages: 449 - 457
Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy Pietro FerraraPaolo A. CortesiLorenzo G. Mantovani Original Research Article Open access 16 March 2021 Pages: 459 - 468
First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects Ramakrishna NirogiGopinadh BhyrapuneniVeera Raghava Chowdary Palacharla Original Research Article 31 March 2021 Pages: 469 - 482
Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report Hai-Yan TuYang-Si LiYi-Long Wu Research Letter Open access 16 April 2021 Pages: 483 - 488
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma Kenneth R. ChapmanHenrik WatzIvan Nikolaev Research Letter Open access 17 April 2021 Pages: 489 - 492
Comment on ‘Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III trials’ Marco Tullio Suadoni Letter to the Editor 07 April 2021 Pages: 493 - 494
Authors’ Reply to ‘Comment on: Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials’ Akshaya Srikanth BhagavathulaNadya Obaid Al MatrooshiJamal Rahmani Letter to the Editor 11 April 2021 Pages: 495 - 496
Correction to: Efficacy of Collagenase Clostridium histolyticum (Xiapex®) in Patients with the Acute Phase of Peyronie’s Disease Andrea CocciFabrizio Di MaidaNicola Mondaini Correction 17 April 2021 Pages: 497 - 497